Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Phase II Study of Panobinostat in Paediatric& Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma& Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma
Protocol ID
ACCT008 (NORTH)
Disease (Sub Disease)
Brain and Spinal Tumours (ATRT)
Solid tumours (Neuroblastoma)
Solid tumours (Osteosarcoma)
Diagnosis Stage
New diagnosis
Relapse/refractory
Location
NSW, QLD, VIC, WA, SA, NZ, TAS
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Royal Hobart Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 40 years of age
ANZCTR
ACTRN12618000321246
Back to Registry
Study Title A Phase II Study of Panobinostat in Paediatric& Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma& Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma
Protocol ID ACCT008 (NORTH)
Disease (Sub Disease) Brain and Spinal Tumours (ATRT)
Solid tumours (Neuroblastoma)
Solid tumours (Osteosarcoma)
Diagnosis Stage New diagnosis
Relapse/refractory
Location NSW / QLD / VIC / WA / SA / NZ / TAS
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Links https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374371&isReview=true
Trial Status Open
Trial Open Date 17/08/2018
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Royal Hobart Hospital / Christchurch Hospital / Starship Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility up to 40 years of age
ANZCTR ACTRN12618000321246